Works matching IS 10837159 AND DT 2019 AND VI 24 AND IP 6
Results: 47
Publish or Perish v2.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 723, doi. 10.1634/theoncologist.2019-0319
- By:
- Publication type:
- Article
Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 725, doi. 10.1634/theoncologist.2019-0165
- By:
- Publication type:
- Article
Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e292, doi. 10.1634/theoncologist.2018-0890
- By:
- Publication type:
- Article
Clinical Characteristics and Survival of Patients with Malignant Ovarian Tumors in Addis Ababa, Ethiopia.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e303, doi. 10.1634/theoncologist.2018-0869
- By:
- Publication type:
- Article
Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real‐World Practice.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e397, doi. 10.1634/theoncologist.2019-0039
- By:
- Publication type:
- Article
Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e284, doi. 10.1634/theoncologist.2018-0803
- By:
- Publication type:
- Article
Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e312, doi. 10.1634/theoncologist.2018-0465
- By:
- Publication type:
- Article
Diagnosis and Management of Immune Checkpoint Inhibitor‐Associated Renal Toxicity: Illustrative Case and Review.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 735, doi. 10.1634/theoncologist.2018-0764
- By:
- Publication type:
- Article
microRNA‐431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e241, doi. 10.1634/theoncologist.2018-0849
- By:
- Publication type:
- Article
Clinical Activity of Nivolumab for Human Papilloma Virus‐Related Juvenile‐Onset Recurrent Respiratory Papillomatosis.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 829, doi. 10.1634/theoncologist.2018-0505
- By:
- Publication type:
- Article
Reflecting on the Human Connection.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 864, doi. 10.1634/theoncologist.2019-0078
- By:
- Publication type:
- Article
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 820, doi. 10.1634/theoncologist.2018-0433
- By:
- Publication type:
- Article
Hospital Volume Versus Good Clinical Practice.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e400, doi. 10.1634/theoncologist.2019-0028
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e401, doi. 10.1634/theoncologist.2019-0052
- By:
- Publication type:
- Article
Combination Cisplatin‐Epirubicin‐Paclitaxel Therapy for Metastatic Extramammary Paget's Disease.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e394, doi. 10.1634/theoncologist.2018-0856
- By:
- Publication type:
- Article
From Diagnostic‐Therapeutic Pathways to Real‐World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR‐Positive Non‐Small Cell Lung Cancer (MOST Study).
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e318, doi. 10.1634/theoncologist.2018-0712
- By:
- Publication type:
- Article
Managing Pulmonary Toxicities Associated with Immunotherapy: A Case Discussion.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 730, doi. 10.1634/theoncologist.2018-0241
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e327, doi. 10.1634/theoncologist.2018-0618
- By:
- Publication type:
- Article
A Phase II Study of Genexol‐PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 751, doi. 10.1634/theoncologist.2019-0070
- By:
- Publication type:
- Article
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e275, doi. 10.1634/theoncologist.2018-0794
- By:
- Publication type:
- Article
A Case of Donor‐Transmitted Non‐Small Cell Lung Cancer After Liver Transplantation: An Unwelcome Guest.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e391, doi. 10.1634/theoncologist.2018-0517
- By:
- Publication type:
- Article
Diagnosis and Treatment Monitoring of a Patient with Gastrointestinal Stromal Tumor by Next‐Generation Sequencing and Droplet Digital Polymerase Chain Reaction Assay of a PDGFRA Mutation in Plasma‐Derived Cell‐Free Tumor DNA.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e387, doi. 10.1634/theoncologist.2018-0460
- By:
- Publication type:
- Article
Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S‐1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 749, doi. 10.1634/theoncologist.2018-0900
- By:
- Publication type:
- Article
The Increasingly Complicated Approach to Rectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 728, doi. 10.1634/theoncologist.2018-0355
- By:
- Publication type:
- Article
Retrospective Analysis of Taxane‐Based Therapy in Small Bowel Adenocarcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e384, doi. 10.1634/theoncologist.2018-0573
- By:
- Publication type:
- Article
An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 747, doi. 10.1634/theoncologist.2018-0838
- By:
- Publication type:
- Article
Patient‐Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 762, doi. 10.1634/theoncologist.2018-0590
- By:
- Publication type:
- Article
Safety and Activity of Sorafenib in Addition to Vinflunine in Post‐Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 745, doi. 10.1634/theoncologist.2018-0795
- By:
- Publication type:
- Article
Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 743, doi. 10.1634/theoncologist.2018-0243
- By:
- Publication type:
- Article
Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 772, doi. 10.1634/theoncologist.2018-0257
- By:
- Publication type:
- Article
Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 798, doi. 10.1634/theoncologist.2018-0291
- By:
- Publication type:
- Article
Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long‐Term Outcomes Based on Conditional Survival.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e260, doi. 10.1634/theoncologist.2018-0220
- By:
- Publication type:
- Article
"As Long as You Ask": A Qualitative Study of Biobanking Consent—Oncology Patients' and Health Care Professionals' Attitudes, Motivations, and Experiences—the B‐PPAE Study.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 844, doi. 10.1634/theoncologist.2018-0233
- By:
- Publication type:
- Article
How Does a Supervised Exercise Program Improve Quality of Life in Patients with Cancer? A Concept Mapping Study Examining Patients' Perspectives.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e374, doi. 10.1634/theoncologist.2017-0613
- By:
- Publication type:
- Article
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e338, doi. 10.1634/theoncologist.2018-0121
- By:
- Publication type:
- Article
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)‐ERIBE.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e232, doi. 10.1634/theoncologist.2017-0676
- By:
- Publication type:
- Article
Phase Angle and the Diagnosis of Impending Death in Patients with Advanced Cancer: Preliminary Findings.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e365, doi. 10.1634/theoncologist.2018-0288
- By:
- Publication type:
- Article
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 791, doi. 10.1634/theoncologist.2018-0334
- By:
- Publication type:
- Article
Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e358, doi. 10.1634/theoncologist.2018-0244
- By:
- Publication type:
- Article
Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy‐Induced Nausea and Vomiting: A Systematic Review and Network Meta‐Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e347, doi. 10.1634/theoncologist.2018-0140
- By:
- Publication type:
- Article
Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 812, doi. 10.1634/theoncologist.2018-0255
- By:
- Publication type:
- Article
Assessment of NETest Clinical Utility in a U.S. Registry‐Based Study.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 783, doi. 10.1634/theoncologist.2017-0623
- By:
- Publication type:
- Article
Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e251, doi. 10.1634/theoncologist.2018-0089
- By:
- Publication type:
- Article
Osimertinib for EGFR‐Mutant Lung Cancer with Brain Metastases: Results from a Single‐Center Retrospective Study.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 836, doi. 10.1634/theoncologist.2018-0264
- By:
- Publication type:
- Article
Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 753, doi. 10.1634/theoncologist.2017-0602
- By:
- Publication type:
- Article
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 857, doi. 10.1634/theoncologist.2018-0160
- By:
- Publication type:
- Article
Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis‐2N0 After Preoperative Radiotherapy and Surgery from a Population‐Based Propensity Score Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 803, doi. 10.1634/theoncologist.2017-0600
- By:
- Publication type:
- Article